isosorbide dinitrate has been researched along with Blood Clot in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, Y; Higashijima, N; Ishida, H; Ishizuka, N; Kawamura, Y; Takahari, Y; Tamura, N | 1 |
| Arderiu, G; Escolar, G; Hernandez, MR; Pino, M; Serradell, M; Tonda, R | 1 |
| Badimon, JJ; Choi, BG; Ibanez, B; Salas, E; Vilahur, G; Viles-Gonzalez, JF; Zafar, MU | 1 |
| Badimon, L; Padró, T; Pena, E; Vilahur, G | 1 |
| Bielawiec, M; Breddin, H; Krupiński, K | 1 |
| Allix, M; Boulu, R; Guillou, J; Plotkine, M | 1 |
| Fitscha, P; O'Grady, J; Rauscha, F; Rogatti, W; Sinzinger, H; Vane, JR | 1 |
7 other study(ies) available for isosorbide dinitrate and Blood Clot
| Article | Year |
|---|---|
Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production.
Topics: Animals; Anti-Arrhythmia Agents; Arteries; Cells, Cultured; Chlorides; Collagen; Decanoic Acids; Endothelium, Vascular; Enzyme Inhibitors; Ferric Compounds; Humans; Hydroxy Acids; Isosorbide Dinitrate; Male; Mice; Mice, Inbred ICR; Mitochondria; NG-Nitroarginine Methyl Ester; Nicorandil; Nitric Oxide Synthase Type III; Oxidative Stress; Platelet Aggregation; Potassium Channels; Reactive Oxygen Species; Thrombosis; Umbilical Veins; Vasodilator Agents | 2009 |
Antithrombotic effect of a new nitric oxide donor (LA419) on experimental thrombogenesis.
Topics: Animals; Blood Platelets; Collagen; Fibrinolytic Agents; Horses; Humans; Isosorbide Dinitrate; Models, Biological; Nitric Oxide Donors; Platelet Activation; Platelet Adhesiveness; Rabbits; Thrombosis | 2005 |
A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Drug Evaluation, Preclinical; Female; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Isosorbide Dinitrate; Male; Nitric Oxide Donors; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Receptors, Fibrinogen; Thrombosis | 2007 |
Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Topics: Administration, Oral; Animals; Blood Coagulation; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Female; Fibrinolytic Agents; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Disulfide-Isomerases; Proteomics; Purinergic P2 Receptor Antagonists; Random Allocation; Receptors, Purinergic P2; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Thrombosis; Ticlopidine; Vasodilator Agents | 2007 |
[Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil in a laser-induced thrombosis model].
Topics: Animals; Dose-Response Relationship, Drug; Isosorbide Dinitrate; Lasers; Male; Mesenteric Arteries; Molsidomine; Platelet Adhesiveness; Rats; Rats, Wistar; Thrombolytic Therapy; Thrombosis; Verapamil | 1993 |
[Experimental antithrombotic activity of oral isosorbide dinitrate].
Topics: Administration, Oral; Animals; Arginine; Aspirin; Isosorbide Dinitrate; Male; NG-Nitroarginine Methyl Ester; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Research Design; Thrombosis | 1992 |
Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivo.
Topics: Adult; Aged; Alprostadil; Blood Platelets; Cardiovascular Diseases; Cyclic GMP; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indium Radioisotopes; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Organometallic Compounds; Oxyquinoline; Radionuclide Imaging; Random Allocation; Thrombosis | 1990 |